mrd testing in acute leukemias
Published 5 years ago • 720 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
1:53
what clinicians need to know about mrd testing for acute leukemias
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
5:19
circulating micrornas as mrd biomarkers in pediatric all
-
4:21
mrd as a monitoring technique of allosct and car-t in aml/all
-
1:46
standardization mrd monitoring in clinical trials
-
3:50
mrd testing in leukemia, lymphoma and myeloma
-
1:30
the clinical application of mrd testing in aml
-
2:36
mrd testing in aml: the next steps in 2019
-
56:44
40 years of mrd. a review of flow cytometry as an advanced technique for b-all monitoring
-
8:53
how is mrd testing done?
-
7:46
updates in aml treatment and research from asco 2023
-
1:49
bringing precision medicine and mrd into clinical strategies
-
1:32
methods to evaluate mrd in aml
-
1:11
are idh mutations good minimal residual disease (mrd) markers in acute myeloid leukemia (aml)?
-
1:02
challenges with measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
2:18
the utility of measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
2:23
the role of mrd monitoring using mfc for aml: a real-world study
-
1:26
the current role of mrd in aml and challenges with implementing this in clinical practice
-
1:04
real-world findings of mrd by mfc in aml
-
1:25
mrd testing will be a part of future aml clinical trials
-
1:22
methods to measure mrd & its role in predicting patient outcomes in aml